53 results
Page 2 of 3
8-K
EX-99.1
qqafhj
28 Mar 22
Immunome Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
EX-99.1
4deo7lja5c
11 Mar 22
FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
2:33pm
8-K
EX-99.1
r9a0g3skjaew3
8 Feb 22
Other Events
8:27am
8-K
EX-99.1
xoctnl
10 Jan 22
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
4:52pm
8-K
EX-99.1
1mqr0c kf2d9
29 Nov 21
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
7:14am
8-K
EX-99.1
ez48x653x5sdqjnflj
18 Oct 21
Regulation FD Disclosure
4:27pm
8-K
29h5932gwe4agug
18 Oct 21
Regulation FD Disclosure
4:27pm
8-K
mw2n7kmh cbb
21 Sep 21
Regulation FD Disclosure
7:40am
8-K
EX-99.1
izwyvr 02
21 Sep 21
Regulation FD Disclosure
7:40am
8-K
9dbjs
8 Sep 21
Other Events
4:55pm
8-K
EX-99.1
6vk0yf0dmhi8h6frsds
8 Sep 21
Other Events
4:55pm
8-K
EX-99.1
ce06hy0v ccpws
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.2
pncmgfeo5rlpr49wfge
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
bpibemss48r9mww
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.1
6svld4139c
17 Jun 21
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D. to Board of Directors
4:55pm
8-K
EX-99.1
ywot16j8lxye7d
20 May 21
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
9:07am
8-K
EX-99.1
gaw0v383p9ck5wtzo2h
12 May 21
Immunome Reports First Quarter 2021 Financial Results
6:05am
8-K
EX-99.1
aql a8wdcm2ciggl
26 Apr 21
Regulation FD Disclosure
6:07am